Study of Suramin in Subjects With Furosemide-Resistant AKI
Public ClinicalTrials.gov record NCT04496596. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Double-Blind, Placebo-controlled Study of Suramin in Subjects With Furosemide-Resistant Acute Kidney Injury (AKI): Efficacy in Preventing Dialysis Dependent AKI
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a prospective, double-blind, randomized, placebo-controlled study to assess the effects of suramin as a potential treatment option to prevent subjects with AKI from progressing to Kidney Disease Improving Global Outcomes (KDIGO) Stage III or dialysis dependent AKI.
Study identification
- NCT ID
- NCT04496596
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 68 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 12, 2020
- Primary completion
- Apr 16, 2023
- Completion
- Dec 21, 2023
- Last update posted
- May 2, 2023
2020 – 2023
United States locations
- U.S. sites
- 12
- U.S. states
- 10
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Arkansas Medical Sciences (UAMS) | Little Rock | Arkansas | 72205 | — |
| California Institute of Renal Research | La Mesa | California | 91942 | — |
| Ronald Reagan UCLA Medical Center | Los Angeles | California | 900953 | — |
| Emory University School of Medicine | Atlanta | Georgia | 30303 | — |
| Emory Johns Creek Hospital | Johns Creek | Georgia | 30097 | — |
| University of Kentucky | Lexington | Kentucky | 40536 | — |
| University of Missouri - Dept. of Surgery | Columbia | Missouri | 65212 | — |
| University of New Mexico Health Science Center | Albuquerque | New Mexico | 87131 | — |
| New York-Presbyterian Medical Center of Queens | Flushing | New York | 11355 | — |
| Wake Forest Baptist Medical Center | Winston-Salem | North Carolina | 27157-1009 | — |
| Southeast Renal Research Institute | Chattanooga | Tennessee | 37404 | — |
| Baylor Scott and White Research Institute - Dallas Clinical Trials Office | Dallas | Texas | 75246 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04496596, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 2, 2023 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04496596 live on ClinicalTrials.gov.